Macular Degeneration

Lucentis, a drug against the eye disease macular degeneration, was approved in China

Japan researchers close in on stem cell trial

Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.
 

Cell transplants boost vision of night-blind mice: study

Night-blind mice had their vision boosted by implants of light-sensing nerve cells in a laboratory test that may hold promise for treating some forms of blindness, scientists said Wednesday.
 

British actress Judi Dench says not going blind

LONDON (Reuters) - Oscar-winning British actress Judi Dench, who has revealed she is suffering from a degenerative eye condition, played down concern over her sight on Monday, saying she was not going blind.
 

British actress Judi Dench says sight failing

LONDON (Reuters) - Oscar-winning British actress Judi Dench has lost part of her eyesight and struggles to read film scripts or see people sitting directly in front of her.
 

Veteran actress Judi Dench battling to save sight

Oscar-winning British actress Judi Dench, who plays 'M' in the James Bond movies, revealed Saturday that she is battling to save her eyesight after being diagnosed with a degenerative disorder.
 

Veteran actress Judi Dench battles to save her sight

Oscar-winning actress Judi Dench, who plays 'M' in the James Bond movies, revealed Saturday that she is battling to save her eyesight after being diagnosed with a degenerative disorder.
 

Judi Dench fights to save eyesight

Leading actress Judi Dench has said she is battling to save her eyesight after being diagnosed with macular degeneration, which can cause blindness.
 

Study confirms groundbreaking advance in stem cells

The first use of embryonic stem cells in humans eased a degenerative form of blindness in two volunteers and showed no signs of any adverse effects, according to a study published by The Lancet on Monday.
 

First patients shown to improve with embryonic stem cells

NEW YORK (Reuters) - Before treatment, the 51-year-old graphic artist was legally blind, unable to read a single letter on a standard eye chart. She has suffered from Stargardt's disease, the most common form of macular degeneration in young patients, since she was a teenager, and it was getting progressively worse.
 

First patients shown to improve with embryonic stem cells

NEW YORK (Reuters) - Before treatment, the 51-year-old graphic artist was legally blind, unable to read a single letter on a standard eye chart. She has suffered from Stargardt's disease, the most common form of macular degeneration in young patients, since she was a teenager, and it was getting progressively worse.
 

China approves Novartis drug Lucentis

Swiss pharmaceutical group Novartis said Wednesday it has approval in China for Lucentis, a drug against the eye disease macular degeneration.
 

Analysis: Stem cell research: win some, lose some

LONDON (Reuters) - A decision by one of the biggest names in stem cell research to throw in the towel will not stop other pioneering work that could yet produce cures for blindness and help mend broken hearts.
 

US-HEALTH Summary

Keeping brain sharp may ward off Alzheimer's protein
 

US-SCIENCE Summary

Sun hurls strong geomagnetic storm toward Earth
 

US-SCIENCE Summary

Psychedelic mushroom trips point to new depression drugs
 

US-SCIENCE Summary

Gingrich calls for moon base, space contests
 

US-SCIENCE Summary

Gingrich calls for moon base, space contests
 

Daily aspirin tied to risk of vision loss:study

(Reuters) - Seniors who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, according to a European study.
 

Daily aspirin tied to risk of vision loss

NEW YORK (Reuters Health) - Seniors who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, a new European study reports.
 

U.S. firm wins UK embryonic stem cell trial go-ahead

LONDON (Reuters) - British drug regulators have granted approval to Advanced Cell Technology to conduct the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness, the firm said on Thursday.
 

Facts from the Wikipedia page:

Macular degeneration
Classification and external resources
ICD-10H35.3
ICD-9362.50
DiseasesDB11948
MedlinePlus001000
eMedicinearticle/1223154
MeSHD008268